Jeffrey M. Dayno
President, CEO & DirectorDr. Jeffrey M. Dayno M.D. is Director of Life Sciences Pennsylvania. Dr. Dayno serves as President, Chief Executive Officer and Director at Harmony Biosciences, LLC since 2023 and served as its Interim President and Chief Executive Officer since January 06, 2023 until April 2023 and served as its Executive Vice President. Dr. Dayno has been an Executive Vice President of Harmony Biosciences Holdings, Inc. from November 2017 until January 06, 2023. He served as Chief Medical Officer for Harmony Biosciences Holdings, Inc. since November 2017 until April 2023. He joined Harmony Biosciences Holdings, Inc. in November 2017. He is a neurologist with experience in clinical/academic medicine followed by experience in leadership roles at Merck & Co., Cephalon and ViroPharma, building and leading clinical, regulatory and medical affairs teams toward multiple NDA approvals and medical support of successful product launches. Dr. Dayno also served as Chief Medical Officer of Eaglet Co., (now known as Zyla Life Sciences), from July 2014 to October 2017. He served as the Chief Medical Officer at Egalet Corporation since July 31, 2014 until November 10, 2017. Dr. Dayno served as the President at Labopharm USA Inc. He served as Chief Medical Officer at Labopharm Inc. since May 5, 2010, where he was a Member of several senior R&D leadership teams. He was responsible for leading the clinical activities for Labopharm's drug development programs, as well as overseeing its medical affairs functions, including medical information and pharmacovigilance, for all commercialized products. He was Vice President of medical affairs at Cephalon, Inc., from 2005 to 2010. Dr. Dayno started his career in the pharmaceutical industry in 1998 at Merck & Co., Inc. Dr. Dayno spent certain years in clinical and academic medicine before moving into the pharmaceutical industry. He served as Vice President of Global Medical Affairs at ViroPharma, from August 2011 to January 2014, where he was a Member of several senior R&D leadership teams. He has many years of senior track record of senior pharmaceutical industry experience at both global and emerging biopharmaceutical companies in the realm of medical affairs and pharmaceutical medicine during which time he oversaw and provided strategic guidance to clinical development programs, interacted with regulatory authorities around the world, built and led medical affairs departments and orchestrated the integration of these functions in support of commercial franchises. As a practicing neurologist, Dr. Dayno has clinical experience caring for chronic pain patients. He has held a number of clinical appointments, including clinical assistant professor of neurology, Jefferson Medical College and medical Director of the Jefferson Health Systems Stroke Center Network. He has served as Principal investigator on numerous clinical trials, has published and lectured extensively on various topics in the field of neurology and is a peer reviewer for several scientific journals. Dr. Dayno joined Labopharm from Cephalon, Inc., where he served as Vice President of Medical Services and oversaw a team of Medical Directors in support of commercial franchises. Prior to his tenure at Cephalon, he spent certain years with Merck & Co., Inc. in increasingly senior Medical Services positions, culminating in his role as Senior Director, Medical Services, U.S. Medical & Scientific Affairs. He had been Director at Aprea Therapeutics, Inc (formerly known as Atrin Pharmaceuticals LLC) since November 16, 2016. He held a number of clinical appointments, including Clinical Assistant Professor of Neurology, Jefferson Medical College (Philadelphia) and Medical Director Jefferson Health Systems Stroke Center Network (Philadelphia). He is a Member of the Board of Visitors of Temple University School of Medicine since March 2013 and was the Chairman of the Philadelphia Stroke Council. Dr. Dayno received his Bachelor's degree from Trinity College and his Medical degree from Temple University. He did his residency in Neurology at Temple University Hospital, did a fellowship in Stroke and Cerebrovascular Disorders at Henry Ford Hospital and was Board certified in Neurology.
Positions
- Company NameHarmony Biosciences Holdings, Inc.Stock CodeHRMYPositionPresident, CEO & DirectorColleagues
- JSJeffrey S. AroninFounder & Non-Executive Chairman
- PAPeter AnastasiouSenior Executive VP & COO
- KBKumar BudurExecutive VP and Chief Medical & Scientific Officer
- ASAndrew SerafinExecutive VP & Chief Strategy Officer
- AWAndreas WickiIndependent Director
- JAJuan Alfonso SabaterIndependent Director
- GLGary L. SenderIndependent Director
